| Ytd | 159.40% | |
| 1y | 495.42% |
| Open | 208.06 | Prev Close | 206.97 | Low | 202.01 | High | 208.25 | Mkt Cap | 43.89B |
| Vol | 816.19K | Avg Vol | 2.62M | EPS | -8.82 | P/E | -23.41 | Forward P/E | -30.82 |
| Beta | 1.39 | Short Ratio | 4.41 | Inst. Own | 99.35% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 176.91 | 200-d Avg | 119.82 | 1yr Est | 214.71 |
Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) hit a new 52-week high during mid-day tr
Companies also enter a separate regional rights agreement granting BeOne exclusive development and c
SAN CARLOS, Calif. & REDWOOD CITY, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Na
Revolution Medicines is evolving from a clinical-stage biotech to a near-term commercial oncology pl
Revolution Medicines posts a wider-than-expected loss in Q2 and raises its 2026 expense outlook agai
Revolution Medicines NASDAQ: RVMD said its second-quarter 2026 results reflected continued investmen
Revolution Medicines, Inc. (RVMD) Q2 2026 Earnings Call Transcript
REDWOOD CITY, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a
Amundi lifted its position in Revolution Medicines, Inc. (NASDAQ: RVMD) by 590.5% during the first q
First Trust Advisors LP grew its holdings in shares of Revolution Medicines, Inc. (NASDAQ: RVMD) by
This billionaire investor is betting big on a revolutionary approach in treating pancreatic cancer.
Avidity Partners Management LP bought a new position in shares of Revolution Medicines, Inc. (NASDAQ
But is that performance sustainable?
REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a
Revolution Medicines' FDA filing for daraxonrasib in metastatic pancreatic cancer enters an accelera
REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a
California Public Employees Retirement System trimmed its holdings in Revolution Medicines, Inc. (NA
Bessemer Group Inc. reduced its holdings in Revolution Medicines, Inc. (NASDAQ: RVMD) by 59.2% durin
Needham analyst Ami Fadia maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Revolution Medicines aims to replace chemotherapy with target treatments. Its positive Phase 3 findi
The S&P 500 is up 10.3% YTD, and Wall Street is convinced the markets have more room to run, particu
Axsome has a solid late-stage pipeline and growing commercialized drugs. Revolution aims to revoluti
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Stanley Druckenmiller cut Amazon, exited Alphabet while increasing bets on Argentina, commodities, s
Tech stocks slide as OpenAI's user growth miss reignites AI capex skepticism, while oil rallies
U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimate
Large-cap stocks surged last week as catalysts from short squeezes to innovation-driven momentum fue
U.S. stocks were mixed on Monday, with the Dow Jones falling over 200 points. Leggett & Platt ro
Natural gas jumps over 30% on winter storm disruptions, silver posts its biggest daily surge since 2
Pharmaceuticals giant, Merck & Co. Inc. (NYSE: MRK), is reportedly in talks to acquire cancer dr
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investo